The application of peripheral blood immune profiling in personalized treatment of locally advanced and advanced lung cancer: a nomogram approach
Peripheral blood lymphocyte subsets are promising non-invasive biomarkers for predicting treatment responses in locally advanced and advanced lung cancer patients, particularly with immunotherapy. The developed nomogram models enhance predictive accuracy, supporting personalized treatment decisions.
Authors
- Feifei Teng (ORCID: https://orcid.org/0000-0001-8101-9405)
- Tianwen Yin
- Chuanwang Miao
- Jinming Yu (ORCID: https://orcid.org/0000-0001-5933-9912)
- Qipeng Yuan (ORCID: https://orcid.org/0000-0002-7899-1487)
- Yikun Li (ORCID: https://orcid.org/0000-0002-2117-8057)
- Sun Qixin (ORCID: https://orcid.org/0000-0001-6233-6114)
- Shan Zhu
- Tao Zhang (ORCID: https://orcid.org/0000-0002-9543-5474)
Institutions
- Weifang Medical University (CN)
- Union Hospital (HK)
- Shandong Tumor Hospital (CN)
- Shandong Provincial Hospital (CN)
- Shandong First Medical University (CN)
- Huazhong University of Science and Technology (CN)
Publication Details
- Journal
- Frontiers in Oncology
- Published
- 2025-09-01
- DOI
- https://doi.org/10.3389/fonc.2025.1642829
- Citations
- 1
- Primary Topic
- Cancer Immunotherapy and Biomarkers
- Type
- article
- Field-Weighted Citation Impact
- 1.05